# EDGAR Filing Document

**Accession Number:** 0001833141
**File Stem:** 0001062993-25-012841
**Filing Date:** 2025-7
**Character Count:** 3572
**Document Hash:** 224b8410d2197ee491cbd9873fa7a49c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001062993-25-012841.hdr.sgml**: 20250714

**ACCESSION NUMBER**: 0001062993-25-012841

**CONFORMED SUBMISSION TYPE**: 6-K

**PUBLIC DOCUMENT COUNT**: 3

**CONFORMED PERIOD OF REPORT**: 20250714

**FILED AS OF DATE**: 20250714

**DATE AS OF CHANGE**: 20250714

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CYBIN INC.
- **CENTRAL INDEX KEY:** 0001833141
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 000000000
- **STATE OF INCORPORATION:** A6
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** 6-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40673
- **FILM NUMBER:** 251122489

**BUSINESS ADDRESS:**
- **STREET 1:** 100 KING STREET WEST
- **STREET 2:** SUITE 5600
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5X 1C9
- **BUSINESS PHONE:** (908) 764-8385

**MAIL ADDRESS:**
- **STREET 1:** 100 KING STREET WEST
- **STREET 2:** SUITE 5600
- **CITY:** TORONTO
- **STATE:** A6
- **ZIP:** M5X 1C9

------

**UNITED STATES**<br>**SECURITIES AND EXCHANGE COMMISSION**<br>Washington, D.C. 20549<br>**Form 6-K**<br>**REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16**<br>**UNDER THE SECURITIES EXCHANGE ACT OF 1934**

For the month of <u>**July, 2025**</u>.

Commission File Number: <u>**001-40673**</u>

<br>**<u>Cybin Inc.</u>**<br>(Exact Name of Registrant as Specified in Charter)<br><u>**100 King Street West, Suite 5600, Toronto, Ontario, M5X 1C9**</u>

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ☐ Form 40-F ☒

------

**INCORPORATION BY REFERENCE**

Exhibit 99.1 of this Form 6-K of Cybin Inc. (the "Company") is hereby incorporated by reference into the [<u>Registration Statement on Form F-10 (File No. 333-284173)</u>](http://www.sec.gov/Archives/edgar/data/1833141/000106299325000510/formf10.htm) of the Company, as amended or supplemented.

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **CYBIN INC.** | **CYBIN INC.** |
|  | (Registrant) | (Registrant) |
| Date: July 14, 2025 | By: | */s/ Doug Drysdale* |
|  | Name: | Doug Drysdale |
|  | Title: | Chief Executive Officer |

---

------

<u>**EXHIBIT INDEX**</u>

[99.1](exhibit99-1.htm) [Consent of Aird & Berlis LLP](exhibit99-1.htm)

------

## Exhibit 99.1

------

![](exhibit99-1xu006.jpg)

July 14, 2025

<u>**VIA EDGAR**</u>

Cybin Inc.

100 King Street West, Suite 5600

Toronto, Ontario

M5X 1C9

Dear Sirs/Mesdames:

---

| | |
|:---|:---|
| **Re:** | Cybin Inc. (the "**Company**") - Prospectus Supplement dated July 14, 2025 to the Short Form Base Shelf Prospectus dated August 17, 2023, as amended on December 22, 2023, April 8, 2024 and January 6, 2025 (the "**Prospectus Supplement**") |

---

We hereby consent to the reference to our firm name under the headings "Experts" and "Documents Filed as Part of the Registration Statement" in the Prospectus Supplement, which forms part of the registration statement on Form F-10 (File No. 333-284173), as amended, filed by the Company with the United States Securities and Exchange Commission and to the reference to our advice under the heading of "Enforcement of Civil Liabilities by U.S. Investors".

Yours very truly,

*"/s/ AIRD & BERLIS LLP"*

------